SAMAHA ELI purchased 21.4% of their position (1.50M shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market purchase worth $13.12M — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/3/2024ACC: 0001877589-24-000001
+1.50M
Net shares
Net buyer
$13.12M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.50M acquired
Non-Derivative Transactions2
COM
Indirect
Shares
+999.80K
Price / share
$8.75
Trade value
$8.75M
% of position
14.3%
5/1/2024
7.01M→8.01M
COM
Indirect
Shares
+499.32K
Price / share
$8.75
Trade value
$4.37M
% of position
6.2%
5/1/2024
8.01M→8.51M
Total
Net shares
+1.50M
Net value
$13.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COM Indirect | 5/1/2024 | P · Purchase | +999.80K | $8.75 | $8.75M | 14.3% | 7.01M | 8.01M |
| COM Indirect | 5/1/2024 | P · Purchase | +499.32K | $8.75 | $4.37M | 6.2% | 8.01M | 8.51M |
| Total | +1.50M | $13.12M | ||||||
Derivative Transactions0
No derivative transactions reported